A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Stress-induced elevations in glucose levels can confound interpretation of data derived from a conscious intraperitoneal insulin tolerance test in mice. In this article, we describe a method to acclimate the mice to handling, injections and blood sampling prior to performing the insulin tolerance test in order to limit stress-induced hyperglycemia.

Abstract

The insulin tolerance test is commonly used in metabolic studies to assess whole body insulin sensitivity in rodents. It is a relatively simple test that involves measurement of blood glucose levels over time following a single intraperitoneal injection of insulin. Given that it is performed in the conscious state and blood is often collected via a tail snip, it has the potential to elicit a stress response from animals due to anxiety associated with handling and blood collection. As such, a stress-induced rise in blood glucose can occur, making it difficult to detect and interpret the primary endpoint measure, namely an insulin-mediated reduction in blood glucose. This has been seen in many mouse strains, and is quite common in diabetic db/db mice, where glucose levels can increase, rather than decrease, after insulin administration. Here, we describe a method of acclimating mice to handling, injections and blood sampling prior to performing the insulin tolerance test. We find that this lowers stress-induced hyperglycemia and results in data that more accurately reflects whole body insulin sensitivity.

Introduction

Metabolic tests in rodents are routinely performed to assess various parameters that regulate glucose homeostasis1. The gold standard for assessing whole-body insulin action in vivo is the hyperinsulinemic-euglycemic clamp2. This test involves administration of insulin to raise circulating insulin levels while glucose is infused to maintain euglycemia. The glucose infusion rate required to maintain euglycemia is indicative of insulin action. While it is a powerful tool in metabolic research, the clamp technique in mice is technically challenging and labor intensive, and thus is not well suited as an initial screening tool in characterizing a metabolic phenotype. For these reasons, the simpler intraperitoneal insulin tolerance test (ITT) is often chosen.

The ITT is performed in the conscious state following a fasting period (typically 4-6 hours). A bolus of insulin is administered intraperitoneally, after which blood glucose is monitored over a timeframe that usually lasts 60 min. Blood glucose levels are expected to fall due to the ability of insulin to facilitate glucose uptake into insulin-sensitive tissues; the degree to which this occurs is indicative of whole-body insulin action. In some cases, it has been shown that glucose levels paradoxically increase, rather than decrease, after insulin administration. This phenomenon is likely attributed to a stress response. Handling, injections and blood sampling can all induce stress3,4,5, resulting in activation of the hypothalamic-pituitary-adrenal axis (HPA) and the autonomic nervous system (ANS)6,7,8. It is well known that both the HPA and ANS contribute to increases in circulating glucose levels9,10,11. The presence of stress-induced hyperglycemia at the beginning of an ITT is problematic, as it interferes with the rate and magnitude of the fall in glucose upon insulin administration12. This can lead to erroneous conclusions regarding the presence of insulin resistance. Thus, to mitigate the confounding impact of stress on glucose levels during an ITT, we have developed a method of acclimating mice to handling, injections and blood sampling prior to performing the ITT.

Protocol

All methods described here have been approved by the VA Puget Sound Health Care System’s Institutional Animal Care and Use Committee.

NOTE: Local requirements for monitoring and/or intervention of animals that experience hypoglycemia may differ from those described here.

1. Fasting (t= -210 min)

  1. After the dark cycle has ended, transfer mice to a new cage with non-nutritious bedding such as cellulose or paper bedding (not corn-cob bedding, which will affect metabolic endpoints if consumed by mice13). Provide mice with ad libitum access to water throughout the fasting period. Be consistent with the fasting time of day and duration across groups of mice. For the data shown, food was removed between 0700 and 0800 hours, which was 1-2 hours after the dark cycle had ended.
  2. Move cage(s) to the location where the ITT will be performed. This should be a quiet space where stressors such as temperature, noise, light or movement are minimized.

2. Acclimation (t= -150 to -60 min)

IMPORTANT: Handle mice as gently as possible. Avoid use of a restraint device if possible.

  1. At -150 min, measure body weight. This will be used for calculation of the volume of insulin that will be administered for the ITT.
  2. Pick up the mouse gently by the tail and rest on a flat tabletop surface while still gently gripping the tail. Use a 20 G needle (or surgical scissors) to make a small incision in the tip of the tail. A drop of blood should begin to form at the site.
  3. Set the mouse on a smooth hard surface and restrain the mouse gently by the tail.
    1. To record blood glucose at this time, place a drop of blood from the tail tip on the test strip of a handheld glucometer. If necessary, very gently massage the tail to obtain a drop of blood.
  4. Draw up 100 µL of sterile saline into an insulin syringe. Pick up the mouse using gentle scruffing and inject intraperitoneally. Record the time of saline injection.
    1. If multiple mice are being studied, inject the mice with saline at 1 min intervals to allow time for subsequent steps below.
  5. At 15 min after saline injection, pick up the mouse gently by the tail. Use gauze to gently dislodge any blood clot on the tail tip.
    1. Optional: Record blood glucose again at this time as described in step 2.3.
  6. At 30 min after the saline injection gently pick up the mouse by the tail. If desired, obtain another blood glucose measurement as described in step 2.3.
  7. Return the mouse to the cage, and repeat for other mice as necessary. Leave mice undisturbed until -90 min.
  8. At -90 min, repeat steps 2.3 through 2.6, including measurement of blood glucose levels if desired.
  9. Return the mouse to the cage, repeat for other mice as necessary. Leave mice undisturbed until the ITT (for which the baseline blood glucose measurement is done at -5 min).

3. Insulin Tolerance Test (t= -5 to +60 min)

  1. Prepare a working solution of regular insulin (CAUTION) in sterile saline, such that the desired dose can be injected at 4 µL/g body weight.
    NOTE: Caution should be used when handling insulin as accidental injection can result in hypoglycemia.
  2. Prepare a 25% (v/v) dextrose solution in sterile saline to have on hand in case mice develop hypoglycemia requiring intervention.
  3. At -5 min, pick up the mouse gently by the tail. Determine the baseline blood glucose level at this time, by placing a drop of blood from the tail tip on the test strip of a handheld glucometer. If necessary, very gently massage the tail to obtain a drop of blood.
  4. Draw up insulin working solution into an insulin syringe (4 µL/g body weight, for a typical dose range of 0.5-2.0 U/kg). Pick up the mouse using gentle scruffing and inject intraperitoneally. Record time of insulin injection.
    1. If multiple mice are being studied, inject the mice with insulin at 1 min intervals to allow time for subsequent blood sampling and data recording below.
  5. At 15 min after insulin injection, pick up the mouse gently by the tail. Use gauze to gently dislodge any blood clot on the tail tip. Determine the blood glucose again at this time as described in step 3.3.
  6. Return the mouse to the cage and monitor for signs of hypoglycemia (e.g., excessive lethargy). If mice develop symptoms of hypoglycemia, measure blood glucose as described in step 5 and administer dextrose if necessary. A mouse undergoing dextrose intervention would be removed from the ITT protocol at this time.
  7. Repeat steps 3.5 and 3.6 at 30 min after insulin injection.
  8. Repeat steps 3.5 and 3.6 at 45 min after insulin injection.
  9. Repeat steps 3.5 and 3.6 at 60 min after insulin injection.
  10. Return the mice to their home cage, containing a few food pellets on the floor of the cage to aid in recovery from the ITT. Continue to monitor for 30 min and if mice have not regained normal activity/behavior follow procedure described in step 3.6.
    NOTE: Figure 1 summarizes the above acclimation and ITT procedure.

Results

Figure 2A and Figure 3A are representative data (individual and mean data, respectively) showing a paradoxical rise in blood glucose levels in diabetic db/db mice in the 15 minutes following insulin administration, consistent with stress-induced hyperglycemia. Note, no rise in blood glucose was evident in the control non-diabetic littermates (db/+ or +/+) that underwent the same procedure. To determine whether acclimation to the ITT procedure was effective in mi...

Discussion

The hyperinsulinemic-euglycemic clamp is considered the gold standard for assessing insulin action in vivo. Modifications to the methodology for performing the clamp have resulted in the technique being done in conscious, unrestrained mice2 that have been previously catheterized using a two-catheter system14 to enable blood sampling via the carotid artery and infusions via the jugular vein. This limits the need to handle or restrain mice during the procedure, thereby reduci...

Disclosures

 The authors have nothing to disclose.

Acknowledgements

This work was supported by the National Institutes of Health grant P30 DK-017047 (University of Washington Diabetes Research Center, Cell Function Analysis Core), and the United States Department of Veterans Affairs, VA Puget Sound Health Care System (Seattle, WA). The contents of this manuscript do not represent the views of the U.S. Department of Veteran Affairs or the United States Government.

Materials

NameCompanyCatalog NumberComments
Dextrose-50Pfizer Injectables00409-6648-16For use if mouse experiences hypoglycemia.
Gauze padsFisher Scientific22037907To dislodge blood clot on the tail tip.
GlucometerAccu-ChekM001_usTo measure blood glucose.
Gram scaleTo measure body weight.
Insulin (Novolin R)Novo Nordisk0169-1833-11For injection.
Insulin syringesVWRBD-329461For injections.
Minute timer
Sterile 20 G needleVWRBD-305175For tail snip.
Sterile salineLifeshield1261699For injections.
Surgical scissorsFine Science Tools14088-10For tail snip.
Test stripsAccu-Chek06908217001_usTo measure blood glucose.

References

  1. Ayala, J. E., et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease Models & Mechanisms. 3 (9-10), 525-534 (2010).
  2. Ayala, J. E., et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. Journal of Visualized Experiments. (57), e3188 (2011).
  3. Balcombe, J. P., Barnard, N. D., Sandusky, C. Laboratory routines cause animal stress. Contemporary Topics in Laboratory Animal Science. 43 (6), 42-51 (2004).
  4. Tabata, H., Kitamura, T., Nagamatsu, N. Comparison of effects of restraint, cage transportation, anaesthesia and repeated bleeding on plasma glucose levels between mice and rats. Lab Animal. 32 (2), 143-148 (1998).
  5. Olfe, J., Domanska, G., Schuett, C., Kiank, C. Different stress-related phenotypes of BALB/c mice from in-house or vendor: alterations of the sympathetic and HPA axis responsiveness. BMC Physiology. 10, 2 (2010).
  6. Ghalami, J., Zardooz, H., Rostamkhani, F., Farrokhi, B., Hedayati, M. Glucose-stimulated insulin secretion: Effects of high-fat diet and acute stress. Journal of Endocrinological Investigation. 36 (10), 835-842 (2013).
  7. Thorens, B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes, Obesity and Metabolism. 13, 82-88 (2011).
  8. Pekow, C. Defining, measuring, and interpreting stress in laboratory animals. Contemporary Topics in Laboratory Animal Science. 44 (2), 41-45 (2005).
  9. Chan, O., Inouye, K., Riddell, M. C., Vranic, M., Matthews, S. G. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol. 28 (2), 87-102 (2003).
  10. Rosmond, R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 30 (1), 1-10 (2005).
  11. Nonogaki, K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 43 (5), 533-549 (2000).
  12. McGuinness, O. P., Ayala, J. E., Laughlin, M. R., Wasserman, D. H. NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse. American Journal of Physiology-Endocrinology and Metabolism. 297 (4), 849-855 (2009).
  13. Zahorsky-Reeves, J., LW, C. Housing mice on corncob bedding versus hardwood chip may confound research models. American Association for Laboratory Animal Science. , (2010).
  14. Niswender, K. D., Shiota, M., Postic, C., Cherrington, A. D., Magnuson, M. A. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. Journal of Biological Chemistry. 272 (36), 22570-22575 (1997).
  15. Ghosal, S., et al. Mouse handling limits the impact of stress on metabolic endpoints. Physiology & Behavior. 150, 31-37 (2015).
  16. Hurst, J. L., West, R. S. Taming anxiety in laboratory mice. Nature Methods. 7 (10), 825-826 (2010).
  17. Ayala, J. E., Bracy, D. P., McGuinness, O. P., Wasserman, D. H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 55 (2), 390-397 (2006).
  18. Barrett, A. M., Stockham, M. A. The effect of housing conditions and simple experimental procedures upon the corticosterone level in the plasma of rats. Journal of Endocrinology. 26, 97-105 (1963).
  19. Heinrichs, S. C. Neurobehavioral consequences of stressor exposure in rodent models of epilepsy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34 (5), 808-815 (2010).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

AcclimationIntraperitoneal Insulin Tolerance TestStress induced HyperglycemiaBlood Glucose LevelsInsulin SensitivityRodent StudiesDiabetic MiceHandling StressGlucose MeasurementBlood Sampling Technique

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved